NICE rejects MS symptom-relieving treatments

NICE has rejected the NHS use of two treatments indicated to relieve certain symptoms of multiple sclerosis (MS).

by
People who are already receiving Sativex or Fampyra on the NHS should be able to continue treatment until they and their NHS clinician decide it is appropriate to stop.
People who are already receiving Sativex or Fampyra on the NHS should be able to continue treatment until they and their NHS clinician decide it is appropriate to stop.

To continue enjoying this article, please sign in. You can register for free for limited further access, or subscribe now for full access to all our content.

Sign In

Trouble signing in?

Reset password: Click here

Need help? Email us

Register

FREE

  • Limited free articles a month 
  • Free email bulletins

Register Now

Subscribe now

Benefits include:

  • Full site access
  • Subscriber exclusive content
  • Exclusive bulletins

Choose a package